Short-term costs of preeclampsia to the United States health care system.
Warren Stevens,Tiffany Shih,Devin Incerti,Thanh G.N. Ton,Henry C. Lee,Desi Peneva,George A. Macones,Bahaeddine M Sibai,Anupam B. Jena +8 more
Reads0
Chats0
TLDR
In 2012, the cost of preeclampsia within the first 12 months of delivery was $2.18 billion in the United States ($1.03 billion for mothers and $1.15 billion for infants), and was disproportionately borne by births of low gestational age.About:
This article is published in American Journal of Obstetrics and Gynecology.The article was published on 2017-09-01 and is currently open access. It has received 183 citations till now. The article focuses on the topics: Population & Health care.read more
Citations
More filters
Journal ArticleDOI
Systematic review of the healthcare cost of bronchopulmonary dysplasia.
TL;DR: In this article, the authors conducted a systematic review of costs associated with bronchopulmonary dysplasia (BPD) in preterm infants and identified a need for studies that estimate costs outside hospitals and after the first year of life.
Journal ArticleDOI
A Comparison of the Cost-Effectiveness of Lifestyle Interventions in Pregnancy
TL;DR: In this article , a decision tree model was constructed to compare lifestyle intervention effects from a novel meta-analysis, and scenario analyses were included for all structured interventions combined and by adding neonatal intensive care unit costs.
Journal ArticleDOI
A Comparison of the Cost-Effectiveness of Lifestyle Interventions in Pregnancy
Cate Bailey,Helen Skouteris,Helen Skouteris,Cheryce L. Harrison,Briony Hill,Shakila Thangaratinam,Helena J. Teede,Zanfina Ademi +7 more
TL;DR: In this paper, a decision tree model was constructed to compare lifestyle intervention effects from a novel meta-analysis and the outcome of interest was cost per case prevented (gestational diabetes, hypertensive disorders in pregnancy, cesarean birth) expressed as an incremental cost-effectiveness ratio (ICER).
Journal ArticleDOI
The effects of an educational programme about preeclampsia on women's awareness: a randomised control trial.
TL;DR: Preeclampsia educational programme is effective in improving preeclampsian awareness and some pregnancy outcomes and needs to be designed by professionals based on an updated evidence and women's needs.
Journal ArticleDOI
Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study.
Akihide Ohkuchi,Hisashi Masuyama,Tatsuo Yamamoto,Takashi Kikuchi,Naoko Taguchi,Cyrill Wolf,Shigeru Saito +6 more
TL;DR: In this article, the authors assessed the economic impact of the introduction of the soluble fms-like tyrosine 1/placental growth factor (sFlt-1/PlGF) ratio cutoff value of ≤38 to rule out the occurrence of preeclampsia in the short term in Asian women.
References
More filters
MonographDOI
Microeconometrics: Methods and Applications
TL;DR: This chapter discusses models for making pseudo-random draw, which combines asymptotic theory, Bayesian methods, and ML and NLS estimation with real-time data structures.
Journal ArticleDOI
WHO analysis of causes of maternal death: a systematic review
TL;DR: Haemorrhage and hypertensive disorders are major contributors to maternal deaths in developing countries and these data should inform evidence-based reproductive health-care policies and programmes at regional and national levels.
Journal ArticleDOI
Circulating Angiogenic Factors and the Risk of Preeclampsia
Richard J. Levine,Sharon Maynard,Cong Qian,Kee-Hak Lim,Lucinda England,Kai F. Yu,Enrique F. Schisterman,Ravi Thadhani,Benjamin P. Sachs,Franklin H. Epstein,Bahaeddine M Sibai,Vikas P. Sukhatme,S. Ananth Karumanchi +12 more
TL;DR: Alterations in the levels of sFlt-1 and free PlGF were greater in women with an earlier onset of preeclampsia and in women in whom preeClampsia was associated with a small-for-gestational-age infant.
Journal ArticleDOI
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.
Jürgen Rehm,Colin Mathers,Svetlana Popova,Svetlana Popova,Montarat Thavorncharoensap,Montarat Thavorncharoensap,Yot Teerawattananon,Jayadeep Patra +7 more
TL;DR: The burden of mortality and disease attributable to alcohol, both globally and for ten large countries, is quantified and concludes that alcohol consumption is one of the major avoidable risk factors, and actions to reduce burden and costs associated with alcohol should be urgently increased.
Related Papers (5)
Hypertension in pregnancy: Executive summary
James M. Roberts,Phyllis August,George Bakris,John R. Barton,Ira M. Bernstein,Maurice L. Druzin,Robert R. Gaiser,Joey P. Granger,Arun Jeyabalan,Donna D. Johnson,S. Ananth Karumanchi,Marshall D. Lindheimer,Michelle Y. Owens,Geroge R. Saade,Bahaeddine M Sibai,Catherine Y. Spong,Eleni Tsigas,Gerald E. Joseph,Nancy O'Reilly,Alyssa Politzer,Sarah Son,Karina Ngaiza +21 more
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik,David Wright,Liona C. Poon,Neil O'Gorman,Argyro Syngelaki,Catalina De Paco Matallana,Ranjit Akolekar,Simona Cicero,D. Janga,Mandeep Singh,Francisca S. Molina,Nicola Persico,Nicola Persico,Jacques Jani,Walter Plasencia,G. Papaioannou,Kinneret Tenenbaum-Gavish,Hamutal Meiri,Sveinbjörn Gizurarson,Kate Maclagan,Kypros H. Nicolaides +20 more